Organ on a Chip Technology: Discussion with Yaakov Nahmias (INTERPHEX 2023)
Yaakov Nahmias, founder and chief scientific officer of Tissue Dynamics, discusses the barriers in implementing organ on a chip technology.
Yaakov Nahmias, founder and chief scientific officer of Tissue Dynamics, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, discusses the barriers in implementing organ on a chip technology as well as the need for researchers and scientists to think critically about the data generated from this technology for pharmaceutical development.
For more INTERPHEX 2023 video content, check this page for updates.
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
